Literature DB >> 27048482

Microbial inhibitors of cysteine proteases.

Mateusz Kędzior1, Rafał Seredyński2, Jan Gutowicz2.   

Abstract

Cysteine proteases are one of the major classes of proteolytic enzymes involved in a number of physiological and pathological processes in plants, animals and microorganisms. When their synthesis, activity and localization in mammalian cells are altered, they may contribute to the development of many diseases, including rheumatoid arthritis, osteoporosis and cancer. Therefore, cysteine proteases have become promising drug targets for the medical treatment of these disorders. Inhibitors of cysteine proteases are also produced by almost every group of living organisms, being responsible for the control of intracellular proteolytic activity. Microorganisms synthesize cysteine protease inhibitors not only to regulate the activity of endogenous, often virulent enzymes, but also to hinder the host's proteolytic defense system and evade its immune responses against infections. Present work describes known to date microbial inhibitors of cysteine proteases in terms of their structure, enzyme binding mechanism, specificity and pathophysiological roles. The overview of both proteinaceous and small-molecule inhibitors produced by all groups of microorganisms (bacteria, archaea, fungi, protists) and viruses is provided. Subsequently, possible applications of microbial inhibitors in science, medicine and biotechnology are also highlighted.

Entities:  

Keywords:  Application; Cysteine protease; Inhibitor; Microbial inhibitor; Microorganism; Virus

Mesh:

Substances:

Year:  2016        PMID: 27048482     DOI: 10.1007/s00430-016-0454-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  182 in total

1.  Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.

Authors:  G Xu; M Cirilli; Y Huang; R L Rich; D G Myszka; H Wu
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

Review 2.  Subterfuge and manipulation: type III effector proteins of phytopathogenic bacteria.

Authors:  Sarah R Grant; Emily J Fisher; Jeff H Chang; Beth M Mole; Jeffery L Dangl
Journal:  Annu Rev Microbiol       Date:  2006       Impact factor: 15.500

3.  Immune response of Anopheles gambiae to the early sporogonic stages of the human malaria parasite Plasmodium falciparum.

Authors:  Rachida Tahar; Christian Boudin; Isabelle Thiery; Catherine Bourgouin
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

Review 4.  Entamoeba histolytica cathepsin-like enzymes : interactions with the host gut.

Authors:  Vanessa Kissoon-Singh; Leanne Mortimer; Kris Chadee
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.

Authors:  M Murata; S Miyashita; C Yokoo; M Tamai; K Hanada; K Hatayama; T Towatari; T Nikawa; N Katunuma
Journal:  FEBS Lett       Date:  1991-03-25       Impact factor: 4.124

6.  Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus.

Authors:  Takehisa Ohbayashi; Atsushi Irie; Yoji Murakami; Magdalena Nowak; Jan Potempa; Yasuharu Nishimura; Masanori Shinohara; Takahisa Imamura
Journal:  Microbiology (Reading)       Date:  2010-11-16       Impact factor: 2.777

7.  A Phytophthora infestans cystatin-like protein targets a novel tomato papain-like apoplastic protease.

Authors:  Miaoying Tian; Joe Win; Jing Song; Renier van der Hoorn; Esther van der Knaap; Sophien Kamoun
Journal:  Plant Physiol       Date:  2006-11-03       Impact factor: 8.340

8.  Cladosporium fulvum overcomes Cf-2-mediated resistance by producing truncated AVR2 elicitor proteins.

Authors:  Rianne Luderer; Frank L W Takken; Pierre J G M de Wit; Matthieu H A J Joosten
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

9.  Inhibition of calpains, by treatment with leupeptin, improves motoneuron survival and muscle function in models of motoneuron degeneration.

Authors:  D Kieran; L Greensmith
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Bacterial expression of human cysteine proteinase inhibitor stefin A.

Authors:  D Fong; T Kartasova; B F Sloane; M M Chan
Journal:  FEBS Lett       Date:  1989-10-23       Impact factor: 4.124

View more
  3 in total

1.  Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System.

Authors:  Karina A Pasquevich; Marianela V Carabajal; Francisco F Guaimas; Laura Bruno; Mara S Roset; Lorena M Coria; Diego A Rey Serrantes; Diego J Comerci; Juliana Cassataro
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

2.  Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer.

Authors:  Taiyuan Li; Qiangqiang Xiong; Zhen Zou; Xiong Lei; Qunguang Jiang; Dongning Liu
Journal:  Oncotarget       Date:  2017-12-08

Review 3.  New Insights into the Role of Cysteine Cathepsins in Neuroinflammation.

Authors:  Anja Pišlar; Lara Bolčina; Janko Kos
Journal:  Biomolecules       Date:  2021-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.